Risk Factors for the Assessment of Patients with Pulmonary Embolism

Author： Fanikos John   Goldhaber Samuel Z.  

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.4, Iss.9, 2006-10, pp. : 871-880

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Should Thrombolytic Therapy Be Used in Patients with Pulmonary Embolism?

By Konstantinides Stavros  

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 2, 2004-01 ,pp. : 69-74

Adis International

Access to resources Recommend Favorite

Antipsychotic use may be associated with an increased risk of pulmonary embolism (PE)

By  

Reactions Weekly, Vol. 1, Iss. 1023, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Assessment of cardiovascular risk and simultaneous treatment of multiple risk factors is important in patients with metabolic syndrome

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 9, 2008-09 ,pp. : 13-17

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of pulmonary embolism

By  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 12, 2002-12 ,pp. : 1719-1725

Informa Healthcare

Access to resources Recommend Favorite

Suspected pulmonary embolism

By Miller Andrew C  

Clinical Medicine, Vol. 4, Iss. 3, 2004-05 ,pp. : 215-219

Royal College Of Physicians

Access to resources Recommend Favorite